Literature DB >> 3166894

The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy.

R A Hawkins1, K Sangster, A Tesdale, P A Levack, E D Anderson, U Chetty, A P Forrest.   

Abstract

A total of 98 breast aspirates from patients with breast cancer have been fixed and stained for oestrogen receptors using the Abbott ERICA kit. In a preliminary series of 41 aspirates, cytochemical staining index (% cells staining x mean intensity) related to the receptor concentration determined biochemically on a subsequent biopsy with a correlation coefficient of +0.65. In a second series of 56 aspirates examined after lysis and cytocentrifugation, the correlation coefficient was +0.73. For 14 patients, the response of the primary tumour to endocrine therapy was assessed objectively by serial clinical and mammographic measurements (Forrest et al., 1986) and was found to relate strongly to the cytochemical staining of the initial aspirate. The potential and limitations of this technique are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3166894      PMCID: PMC2246505          DOI: 10.1038/bjc.1988.166

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Factors influencing the estimation of oestrogen receptors in human malignant breast tumours.

Authors:  H Braunsberg
Journal:  Eur J Cancer       Date:  1975-07       Impact factor: 9.162

2.  Use of monoclonal antiestrogen receptor antibody to evaluate estrogen receptor content in fine needle aspiration breast biopsies.

Authors:  J L Flowers; G V Burton; E B Cox; K S McCarty; G A Dent; K R Geisinger; K S McCarty
Journal:  Ann Surg       Date:  1986-03       Impact factor: 12.969

3.  Monoclonal antibodies to estrophilin: probes for the study of estrogen receptors.

Authors:  G L Greene; F W Fitch; E V Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

4.  Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

Authors:  K S McCarty; L S Miller; E B Cox; J Konrath; K S McCarty
Journal:  Arch Pathol Lab Med       Date:  1985-08       Impact factor: 5.534

5.  Receptors in the management of breast cancer.

Authors:  R A Hawkins
Journal:  Br J Hosp Med       Date:  1985-09

6.  Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors.

Authors:  W J King; E R DeSombre; E V Jensen; G L Greene
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

7.  Histochemical detection of oestrogen receptors in breast carcinoma: a successful technique.

Authors:  R A Hawkins; K Sangster; A Krajewski
Journal:  Br J Cancer       Date:  1986-03       Impact factor: 7.640

8.  Variations in steroid receptors and cyclic AMP binding proteins across human breast cancers: evidence for heterogeneity.

Authors:  R O Senbanjo; W R Miller; R A Hawkins
Journal:  Br J Cancer       Date:  1986-07       Impact factor: 7.640

9.  Reproducibility of measurements of oestrogen-receptor concentration in breast cancer.

Authors:  R A Hawkins; A Hill; B Freedman; S M Gore; M M Roberts; A P Forrest
Journal:  Br J Cancer       Date:  1977-09       Impact factor: 7.640

10.  Semiquantitative oestrogen receptor assay in formalin-fixed paraffin sections of human breast cancer tissue using monoclonal antibodies.

Authors:  J Andersen; T Orntoft; H S Poulsen
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

View more
  7 in total

1.  Analysis of estrogen and progesterone receptors on preoperative fine-needle aspirates.

Authors:  B Frigo; S Pilotti; S Zurrida; L Ermellino; A Manzari; F Rilke
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

2.  Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome.

Authors:  Malini Harigopal; William E Barlow; Greg Tedeschi; Peggy L Porter; I-Tien Yeh; Charles Haskell; Robert Livingston; Gabriel N Hortobagyi; George Sledge; Charles Shapiro; James N Ingle; David L Rimm; Daniel F Hayes
Journal:  Am J Pathol       Date:  2010-02-11       Impact factor: 4.307

3.  ERICA predicts response to tamoxifen in elderly women with breast cancer.

Authors:  N Davies; G Moir; R Carpenter; A Cuthbert; A Herbert; G T Royle; I Taylor
Journal:  Ann R Coll Surg Engl       Date:  1991-11       Impact factor: 1.891

4.  The differing predictive values of oestrogen receptor assays for large breast cancers.

Authors:  D J Gaskell; R A Hawkins; A L Tesdale; K Sangster; U Chetty; A P Forrest
Journal:  Postgrad Med J       Date:  1992-11       Impact factor: 2.401

5.  Response of breast carcinoma to endocrine therapy predicted using immunostained pelleted fine needle aspirates.

Authors:  E Heyderman; S R Ebbs; S E Larkin; B M Brown; A M Haines; T Bates
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

Review 6.  Oestrogen receptor: a stable phenotype in breast cancer.

Authors:  J F Robertson
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

7.  Change in the oestrogen receptor status of breast cancer with age--comparison of two types of assay.

Authors:  D J Gaskell; K Sangster; A L Tesdale; D Carson; R A Hawkins
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.